Key Financial Data Of Group

SAPPORO CLINICAL LABORATORY INC. - Filing #7353045

Concept 2023-04-01 to
2023-12-31
As at
2023-12-31
2023-10-01 to
2023-12-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-12-31
2022-04-01 to
2022-12-31
2022-10-01 to
2022-12-31
Key financial data of group
Business results of group
Net sales
14,852,697,000 JPY
20,127,692,000 JPY
15,250,105,000 JPY
Ordinary profit (loss)
417,882,000 JPY
1,159,449,000 JPY
971,637,000 JPY
Profit (loss) attributable to owners of parent
311,971,000 JPY
568,619,000 JPY
493,187,000 JPY
Comprehensive income
329,435,000 JPY
649,366,000 JPY
583,358,000 JPY
Net assets
11,101,818,000 JPY
10,880,986,000 JPY
10,814,977,000 JPY
Total assets
16,935,020,000 JPY
16,521,281,000 JPY
16,893,292,000 JPY
Basic earnings (loss) per share
93.67
25.72
170.53
147.85
70.53
Diluted earnings per share
Equity-to-asset ratio
0.640 xbrli:pure
0.641 xbrli:pure
0.622 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.